{
  "list": [
    {
      "id": "chads2-score-for-atrial-fibrillation",
      "title": "CHADS2 Score for Atrial Fibrillation Stroke Risk"
    },
    {
      "id": "curb-65-pneumonia-severity-score",
      "title": "CURB-65 Pneumonia Severity Score"
    },
    {
      "id": "ransons-criteria-for-pancreatitis-mortality",
      "title": "Ranson's Criteria for Pancreatitis Mortality"
    },
    {
      "id": "amoxicillin-pediatric-ear-nose-throat",
      "title": "Amoxicillin Pediatric - Ear, Nose, & Throat Infections"
    },
    {
      "id": "atrial-fibrillation-cha2ds2-vasc-score-for-stroke-risk",
      "title": "Atrial Fibrillation CHA2DS2-VASc Score for Stroke Risk"
    },
    {
      "id": "glasgow-coma-scale",
      "title": "Glasgow Coma Scale"
    },
    {
      "id": "apgar-score",
      "title": "Apgar Score"
    },
    {
      "id": "metabolic-syndrome-criteria-aha-nhlbi-2005",
      "title": "Metabolic Syndrome Criteria (AHA/NHLBI 2005)"
    },
    {
      "id": "dvt-probability-wells-score-system",
      "title": "DVT Probability: Wells Score System"
    },
    {
      "id": "tia-prognosis-risk-of-stroke-by-90-days-after-presentation",
      "title": "TIA Prognosis: Risk of Stroke by 90 Days After Presentation"
    },
    {
      "id": "thrombolysis-in-myocardial-infarction-timi-score-for-st-elevation-acute-myocardial-infarction",
      "title": "TIMI Risk Score for STEMI"
    },
    {
      "id": "thrombolysis-in-myocardial-infarction-timi-score-for-unstable-angina-non-st-elevation-myocardial-infarction",
      "title": "TIMI Risk Score for Unstable Angina/NSTEMI"
    },
    {
      "id": "nih-stroke-score",
      "title": "NIH Stroke Score"
    },
    {
      "id": "bleeding-risk-any-bleeding-complication-on-warfarin-therapy",
      "title": "Bleeding Risk on Warfarin Therapy (Any Bleeding Complication)"
    },
    {
      "id": "abcd2-score-for-tia",
      "title": "ABCD2 Score for TIA"
    },
    {
      "id": "has-bled-score-for-major-bleeding-risk",
      "title": "HAS-BLED Score for Major Bleeding Risk"
    },
    {
      "id": "cardiac-risk-index-aaa-surgery-lee",
      "title":"Cardiac Risk Index for AAA Surgery (Lee)"
    },
    {
      "id": "cardiac-risk-index-abdominal-surgery-lee",
      "title": "Cardiac Risk Index for Abdominal Surgery (Lee)"
    },
    {
      "id": "cardiac-risk-index-non-aaa-vascular-surgery-lee",
      "title": "Cardiac Risk Index for Non-AAA Vascular Surgery (Lee)"
    }
  ],
  "calculators": [
    {
      "id": "metabolic-syndrome-criteria-aha-nhlbi-2005",
      "title": "Metabolic Syndrome Criteria (AHA/NHLBI 2005)",
      "type": "points",
      "points": 0,
      "questions": [
        {
          "group": "Criteria",
          "data": [
            {
              "type": "checkbox",
              "label": "Abdominal obesity (Male waist > 101 cm (40 in). Female waist > 88.9cm (35 in)",
              "points": "1"
            },
            {
              "type": "checkbox",
              "label": "Triglycerides ≥ 150 mg/dL or on Triglyceride lowering Rx",
              "points": "1"
            },
            {
              "type": "checkbox",
              "label": "HDL cholesterol (Male < 40; Female < 50) or on HDL improvement Rx",
              "points": "1"
            },
            {
              "type": "checkbox",
              "label": "Blood Pressure ≥130/≥85 or on BP Rx",
              "points": "1"
            },
            {
              "type": "checkbox",
              "label": "Fasting glucose ≥100 mg/dL or on Glucose lowering Rx",
              "points": "1"
            }
          ]
        }
      ],
      "results": {
        "0": ["Absent"],
        "1": ["Absent"],
        "2": ["Absent"],
        "3": ["Present"],
        "4": ["Present"],
        "5": ["Present"]
      },
      "notes": {
        "type": "unordered-list",
        "content": [
          "This criteria set was proposed by the American Heart Association and the National Heart Lung and Blood Institute.",
          "Metabolic syndrome is a constellation of interrelated risk factors of metabolic origin that appear to directly promote the development of atherosclerotic cardiovascular disease.",
          "The predominant underlying risk factors for the syndrome appear to be abdominal obesity and insulin resistance; other associated conditions can be physical inactivity, aging and hormonal imbalance."
        ]
      },
      "references": {
        "type": "ordered-list",
        "content": [
          "Grundy SM, Cleeman JI, Daniels SR, et. al. American Heart Association; National Heart, Lung, and Blood Institute. Diagnosis and management of the metabolic syndrome: an American Heart Association/National Heart, Lung, and Blood Institute Scientific Statement. Circulation. 2005 Oct 25;112(17):2735-52. Epub 2005 Sep 12."
        ]
      }
    },
    {
      "id": "dvt-probability-wells-score-system",
      "title": "DVT Probability: Wells Score System",
      "type": "points",
      "points": 0,
      "questions": [
        {
          "group": "Clinical Findings",
          "data": [
            {
              "type": "checkbox",
              "label": "Paralysis, paresis or recent orthopedic casting of lower extremity",
              "points": "1"
            },
            {
              "type": "checkbox",
              "label": "Recently bedridden (> 3 days) or major surgery within last 4 weeks",
              "points": "1"
            },
            {
              "type": "checkbox",
              "label": "Localized tenderness in deep vein system",
              "points": "1"
            },
            {
              "type": "checkbox",
              "label": "Entire leg is swollen",
              "points": "1"
            },
            {
              "type": "checkbox",
              "label": "Calf swelling >3 cm compared to other leg (measured 10 cm below tibial tuberosity)",
              "points": "1"
            },
            {
              "type": "checkbox",
              "label": "Pitting edema, confined to symptomatic leg",
              "points": "1"
            },
            {
              "type": "checkbox",
              "label": "Collateral non varicose superficial veins",
              "points": "1"
            },
            {
              "type": "checkbox",
              "label": "Active cancer, treatment or palliation within 6 months",
              "points": "1"
            },
            {
              "type": "checkbox",
              "label": "Alternative diagnosis more likely than DVT (Baker's cyst, cellulitis, muscle damage, superficial venous thrombosis, post phlebitic syndrome, inguinal lymphadenopathy, external venous compression)",
              "points": "-2"
            }
          ]
        }
      ],
      "results": {
        "-2": ["Low risk; 5% probability of DVT"],
        "-1": ["Low risk; 5% probability of DVT"],
        "0": ["Low risk; 5% probability of DVT"],
        "1": ["Moderate risk; 17% probability of DVT"],
        "2": ["Moderate risk of DVT; 17% probability of DVT"],
        "3": ["High risk of DVT; 53% probability of DVT"],
        "4": ["High risk of DVT; 53% probability of DVT"],
        "5": ["High risk of DVT; 53% probability of DVT"],
        "6": ["High risk of DVT; 53% probability of DVT"],
        "7": ["High risk of DVT; 53% probability of DVT"],
        "8": ["High risk of DVT; 53% probability of DVT"]
      },
      "notes": {
        "type": "unordered-list",
        "content": [
          "The Wells clinical prediction guide quantifies the probability of deep venous thrombosis (DVT) in patients",
          "The model enables the reliable stratification of patients into high, moderate and low risk categories.",
          "Based on the 2003 Wells study, DVT can be ruled out in a patient who is judged clinically unlikely to have a DVT and who has a negative D-dimer test. Ultrasound testing can be safely omitted in such patients. "
        ]
      },
      "references": {
        "type": "ordered-list",
        "content": [
          "Wells PS, Anderson DR, Bormanis J, et. al. Value of assessment of pretest probability of deep-vein thrombosis in clinical management. Lancet. 1997 Dec 20-27;350(9094):1795-8.",
          "Wells PS, Anderson DR, Rodger M, Forgie M, Kearon C, Dreyer J, Kovacs G, Mitchell M, Lewandowski B, Kovacs MJ. Evaluation of D-dimer in the diagnosis of suspected deep-vein thrombosis. N Engl J Med. 2003 Sep 25;349(13):1227-35."
        ]
      }
    },
    {
      "id": "tia-prognosis-risk-of-stroke-by-90-days-after-presentation",
      "title": "TIA Prognosis: Risk of Stroke by 90 Days After Presentation",
      "type": "points",
      "points": 0,
      "questions": [
        {
          "group": "Criteria",
          "data": [
            {
              "type": "checkbox",
              "label": "Patient > 60 yrs",
              "points": "1"
            },
            {
              "type": "checkbox",
              "label": "Concurrent Diabetes",
              "points": "1"
            },
            {
              "type": "checkbox",
              "label": "TIA lasted > 10 minutes",
              "points": "1"
            },
            {
              "type": "checkbox",
              "label": "Patient experienced weakness during TIA",
              "points": "1"
            },
            {
              "type": "checkbox",
              "label": "Patient experienced speech problems during TIA",
              "points": "1"
            }
          ]
        }
      ],
      "results": {
        "0": ["90 Day Risk of Stroke: Virtually no Risk"],
        "1": ["90 Day Risk of Stroke: 3% Risk"],
        "2": ["90 Day Risk of Stroke: 7% Risk"],
        "3": ["90 Day Risk of Stroke: 11% Risk"],
        "4": ["90 Day Risk of Stroke: 15% Risk"],
        "5": ["90 Day Risk of Stroke: 34% Risk"]
      },
      "references": {
        "type": "ordered-list",
        "content": [
          "Johnston SC, Gress DR, Browner WS, Sidney S. Short-term prognosis after emergency department diagnosis of TIA. JAMA. 2000; 284: 2901-6."
        ]
      }
    },
    {
      "id": "thrombolysis-in-myocardial-infarction-timi-score-for-st-elevation-acute-myocardial-infarction",
      "title": "TIMI Risk Score for STEMI",
      "type": "points",
      "points": 0,
      "questions": [
        {
          "group": "Criteria",
          "data": [
            {
              "type": "checkbox",
              "label": "Diabetes, Hypertension or Angina",
              "points": "1"
            },
            {
              "type": "checkbox",
              "label": "Systolic Blood Pressure <100 mm Hg",
              "points": "3"
            },
            {
              "type": "checkbox",
              "label": "Heart rate > 100 bpm",
              "points": "2"
            },
            {
              "type": "checkbox",
              "label": "Killip class II-IV",
              "points": "2"
            },
            {
              "type": "checkbox",
              "label": "Body weight < 67 kg (150 lb)",
              "points": "1"
            },
            {
              "type": "checkbox",
              "label": "Anterior ST elevation or Left Bundle Branch Block",
              "points": "1"
            },
            {
              "type": "checkbox",
              "label": "Time to treatment > 4 hrs",
              "points": "1"
            }
          ]
        },
        {
          "group": "Age",
          "data": {
            "type": "radio",
            "options": "≥ 75 yrs/65-74 yrs/< 65 yrs",
            "points": "3/2/0"
          }
        }
      ],
      "results": {
        "0": ["30 Day mortality after an MI 0.8%"],
        "1": ["30 Day mortality after an MI 1.6%"],
        "2": ["30 Day mortality after an MI 2.2%"],
        "3": ["30 Day mortality after an MI 4.4%"],
        "4": ["30 Day mortality after an MI 7.3%"],
        "5": ["30 Day mortality after an MI 12%"],
        "6": ["30 Day mortality after an MI 16%"],
        "7": ["30 Day mortality after an MI 23%"],
        "8": ["30 Day mortality after an MI 27%"],
        "9": ["30 Day mortality after an MI 36%"],
        "10": ["30 Day mortality after an MI 36%"],
        "11": ["30 Day mortality after an MI 36%"],
        "12": ["30 Day mortality after an MI 36%"],
        "13": ["30 Day mortality after an MI 36%"],
        "14": ["30 Day mortality after an MI 36%"]
      },
      "notes": {
        "type": "unordered-list",
        "content": [
          "TIMI Risk Score predicts 30 day mortality in patients with ST Elevation Acute Myocardial Infarction (STEMI).",
          "The TIMI Score for STEMI was developed from the InTIME II trial of 15K STEMI patients which included studying these patients for thrombolytics. It did not include patients with cardiogenic shock or severe hypertension (BP >180/>110)",
          "Entry criteria: Chest pain for > 30 minutes, ST elevation, symptom onset < 6 hours, fibrinolytic eligible.",
          "Can be used on patients who are post-cath who may have bleeding risks to objectify risk-benefit of post PCI medications."
        ]
      },
      "references": {
        "type": "ordered-list",
        "content": [
          "Morrow DA, Antman EM, Charlesworth A, et. al. TIMI risk score for ST-elevation myocardial infarction: A convenient, bedside, clinical score for risk assessment at presentation: An intravenous nPA for treatment of infarcting myocardium early II trial substudy. Circulation. 2000 Oct 24; 102(17):2031-7.",
          "Morrow DA, Antman EM, Parsons L, de Lemos JA, Cannon CP, Giugliano RP, McCabe CH, Barron HV, Braunwald E. Application of the TIMI risk score for ST-elevation MI in the National Registry of Myocardial Infarction 3. JAMA. 2001 Sep 19;286(11):1356-9."
        ]
      }
    },
    {
      "id": "thrombolysis-in-myocardial-infarction-timi-score-for-unstable-angina-non-st-elevation-myocardial-infarction",
      "title": "TIMI Risk Score for Unstable Angina/NSTEMI",
      "type": "points",
      "points": 0,
      "questions": [
        {
          "group": "Criteria",
          "data": [
            {
              "type": "checkbox",
              "label": "Age ≥ 65",
              "points": "1"
            },
            {
              "type": "checkbox",
              "label": "≥ 3 CAD risk factors (Hypertension, Diabetes, High Cholesterol, Family History of CAD, Current Smoker)",
              "points": "1"
            },
            {
              "type": "checkbox",
              "label": "Known CAD with > 50% stenosis",
              "points": "1"
            },
            {
              "type": "checkbox",
              "label": "Aspirin use in the past 7 days",
              "points": "1"
            },
            {
              "type": "checkbox",
              "label": "Severe angina ≥ 2 episodes in 24 hrs",
              "points": "1"
            },
            {
              "type": "checkbox",
              "label": "Elevated cardiac markers",
              "points": "1"
            },
            {
              "type": "checkbox",
              "label": "ST deviation ≥ 0.5 mm",
              "points": "1"
            }
          ]
        }
      ],
      "results": {
        "0": ["5% risk at 2 weeks of: Death new or recurrent MI, severe recurrent ischemia requiring urgent revascularization"],
        "1": ["5% risk at 2 weeks of: Death new or recurrent MI, severe recurrent ischemia requiring urgent revascularization"],
        "2": ["8% risk at 2 weeks of: Death new or recurrent MI, severe recurrent ischemia requiring urgent revascularization"],
        "3": ["13% risk at 2 weeks of: Death new or recurrent MI, severe recurrent ischemia requiring urgent revascularization"],
        "4": ["20% risk at 2 weeks of: Death new or recurrent MI, severe recurrent ischemia requiring urgent revascularization"],
        "5": ["26% risk at 2 weeks of: Death, new or recurrent MI, severe recurrent ischemia requiring urgent revascularization"],
        "6": ["41% risk at 2 weeks of: Death, new or recurrent MI, severe recurrent ischemia requiring urgent revascularization"],
        "7": ["41% risk at 2 weeks of: Death, new or recurrent MI, severe recurrent ischemia requiring urgent revascularization"]
      },
      "notes": {
        "type": "unordered-list",
        "content": [
          "Estimates mortality in patients with unstable angina and non-ST elevation myocardial infarction (MI)",
          "Entry criteria: UA or NSTEMI defined as ischemic pain at rest within the past 24 hours with evidence of Coronary Artery Disease (ST segment deviation or + markers)",
          "TIMI Risk Score for Unstable Angina/NSTEMI can be used to help risk stratify patients with anginal symptoms but is better suited for patients with confirmed NSTEMI or unstable angina",
         "TIMI Risk Score for Unstable Angina/NSTEMI is the best known chest pain risk score tool, however newer tools such as the GRACE score provide better risk stratification for low vs. non-low risk patients."
        ]
      },
      "references": {
        "type": "ordered-list",
        "content": [
          "Antman EM1, Cohen M, Bernink PJ, McCabe CH, Horacek T, Papuchis G, Mautner B, Corbalan R, Radley D, Braunwald E. The TIMI risk score for unstable angina/non-ST elevation MI: A method for prognostication and therapeutic decision making. JAMA. 2000 Aug 16;284(7):835-42."
        ]
      }
    },
    {
      "id": "nih-stroke-score",
      "title": "NIH Stroke Score",
      "type": "points",
      "points": 0,
      "questions": [
        {
          "group": "1A: Level of Consciousness",
          "data": {
            "type": "radio",
            "options": "Alert/Not alert, but arousable by minor stimulation/Not alert, requires repeated stimulation to attend/Coma",
            "points": "0/1/2/3"
          }
        },
        {
          "group": "1B: Ask Patient the Month and His/Her Age",
          "data": {
            "type": "radio",
            "options": "Answers both questions correctly/Answers one question correctly/Neither correct",
            "points": "0/1/2"
          }
        },
        {
          "group": "1C: Open and Close Eyes on Command/Grip and release non-paretic hand ",
          "data": {
            "type": "radio",
            "options": "Obeys both correctly/Obeys one correctly/Both incorrect",
            "points": "0/1/2"
          }
        },
        {
          "group": "2: Best Gaze (only horizontal eye movement)",
          "data": {
            "type": "radio",
            "options": "Normal/Partial gaze palsy/Forced deviation",
            "points": "0/1/2"
          }
        },
        {
          "group": "3: Visual Field testing",
          "data": {
            "type": "radio",
            "options": "No visual field loss/Partial hemianopia/Complete hemianopia/Bilateral hemianopia or Patient is bilaterally blind",
            "points": "0/1/2/3"
          }
        },
        {
          "group": "4: Facial Palsy (Ask patient to show teeth or raise eyebrows and close eye)",
          "data": {
            "type": "radio",
            "options": "Normal symmetrical movement/Minor paralysis/Partial paralysis (total or near total paralysis of lower face)/Complete paralysis of one or both sides",
            "points": "0/1/2/3"
          }
        },
        {
          "group": "5A: Motor Function of Right Arm (Count out loud and use your fingers to show patient your count)",
          "data": {
            "type": "radio",
            "options": "No drift for 10 sec/Drift limb holds 90 (or 45 deg) but drifts down before full 10 sec/Some effort against gravity/No effort against gravity/No movement/Amputation or joint fusion",
            "points": "0/1/2/3/4/0"
          }
        },
        {
          "group": "5B: Motor Function of Left Arm (Count out loud and use your fingers to show patient your count)",
          "data": {
            "type": "radio",
            "options": "No drift for 10 sec/Drift limb holds 90 (or 45 deg) but drifts down before full 10 sec/Some effort against gravity/No effort against gravity/No movement/Amputation or joint fusion",
            "points": "0/1/2/3/4/0"
          }
        },
        {
          "group": "6A: Motor Function of Right Leg (Hold the leg at 30 deg, always tested in supine position)",
          "data": {
            "type": "radio",
            "options": "No drift for 5 sec/Drift, leg falls by end of 5 sec/Some effort against gravity/No effort against gravity, leg falls to bed immediately/No movement/Amputation or joint fusion",
            "points": "0/1/2/3/4/0"
          }
        },
        {
          "group": "6B: Motor Function of Left Leg (Hold the leg at 30 deg, always tested in supine position)",
          "data": {
            "type": "radio",
            "options": "No drift for 5 sec/Drift, leg falls by end of 5 sec/Some effort against gravity/No effort against gravity, leg falls to bed immediately/No movement/Amputation or joint fusion",
            "points": "0/1/2/3/4/0"
          }
        },
        {
          "group": "7: Limb Ataxia (Test with eyes open)",
          "data": {
            "type": "radio",
            "options": "None/Present in 1 limb/Present in 2 limbs/Amputation or joint fusion",
            "points": "0/1/2/0"
          }
        },
        {
          "group": "8: Sensory by Pinprick",
          "data": {
            "type": "radio",
            "options": "Normal/Mild to moderate sensory loss/Severe or total sensory loss",
            "points": "0/1/2"
          }
        },
        {
          "group": "9: Best Language (Describe a picture, name items, read sentences)",
          "data": {
            "type": "radio",
            "options": "No aphasia/Mild - Moderate aphasia/Severe aphasia/Mute",
            "points": "0/1/2/3"
          }
        },
        {
          "group": "10: Dysarthria (read or repeat words)",
          "data": {
            "type": "radio",
            "options": "Normal/Mild to Moderate slurring/Severe dysarthria/Intubated or other physical impediment to testing",
            "points": "0/1/2/0"
          }
        },
        {
          "group": "11: Extinction and Inattention (Neglect)",
          "data": {
            "type": "radio",
            "options": "No abnormality/Visual, tactile, auditory, spatial or personal inattention or extinction to bilateral simultaneous stimulation in one of the sensory modalities/Severe hemi-inattention or extinction to more than one modality",
            "points": "0/1/2"
          }
        }
      ],
      "results": {},
      "notes": {
        "type": "unordered-list",
        "content": [
          "The NIH Stroke Score is used to quantify patient stroke severity and to track outcomes, improvement or deteoriation of a stroke",
          "If the patient has a prior known neurological deficit (e.g. Blindness, Quadriplegia, Language barriers etc.), it becomes even more complicated to evaluate. Refer to the NIH Stroke Scale Website for more details.",
          "Scores > 22 are considered very significant and may predict increased complication risk.",
          "If the patient's arm or leg cannot be tested due to amputation or other limitation such as joint fusion, untestable is recorded and no points are counted."
        ]
      },
      "references": {
        "type": "ordered-list",
        "content": [
          "Brott T, Adams HP Jr, Olinger CP, et. al. Measurements of acute cerebral infarction: a clinical examination scale. Stroke. 1989 Jul;20(7):864-70.",
          "NIH Stroke Scale https://stroke.nih.gov/resources/scale.htm"
        ]
      }
    },
    {
      "id": "bleeding-risk-any-bleeding-complication-on-warfarin-therapy",
      "title": "Bleeding Risk on Warfarin Therapy (Any Bleeding Complication)",
      "type": "points",
      "points": 0,
      "questions": [
        {
          "group": "Criteria",
          "data": [
            {
              "type": "checkbox",
              "label": "Age >= 60",
              "points": "1.6"
            },
            {
              "type": "checkbox",
              "label": "Malignacy Present",
              "points": "2.2"
            }
          ]
        },
        {
          "group": "Age",
          "data": {
            "type": "radio",
            "options": "Female/Male ",
            "points": "1.3/0"
          }
        }
      ],
      "results": {
        "0": ["Risk of any bleeding complications: 0-4%"],
        "1.3": ["Risk of any bleeding complications: 6-8%"],
        "1.6": ["Risk of any bleeding complications: 6-8%"],
        "2.2": ["Risk of any bleeding complications: 6-8%"],
        "2.9": ["Risk of any bleeding complications: 6-8%"],
        "3.5": ["Risk of any bleeding complications: 17-26%"],
        "3.8": ["Risk of any bleeding complications: 17-26%"],
        "5.1": ["Risk of any bleeding complications: 17-26%"]
      },
      "references": {
        "type": "ordered-list",
        "content": [
          "Kuijer PM, Hutten BA, Prins MH, Buller HR. Prediction of the risk of bleeding during anticoagulant treatment for venous thromboembolism. Arch Intern Med. 1999; 159: 457-60."
        ]
      }
    },
    {
      "id": "abcd2-score-for-tia",
      "title": "ABCD2 Score for TIA",
      "type": "points",
      "points": 0,
      "questions": [
        {
          "group": "Age ≥ 60 yrs",
          "data": {
            "type": "radio",
            "options": "Yes/No",
            "points": "1/0"
          }
        },
        {
          "group": "Blood Pressure ≥ 140/90 mmHg",
          "data": {
            "type": "radio",
            "options": "Yes/No",
            "points": "1/0"
          }
        },
        {
          "group": "Clinical features of TIA",
          "data": {
            "type": "radio",
            "options": "Unilateral weakness/Speech disturbance without weakness/Other symptoms",
            "points": "2/1/0"
          }
        },
        {
          "group": "Duration of symptoms",
          "data": {
            "type": "radio",
            "options": "≥60 min/10-59 min/<10 min",
            "points": "2/1/0"
          }
        },
        {
          "group": "Diabetes history",
          "data": {
            "type": "radio",
            "options": "Yes/No",
            "points": "1/0"
          }
        }
      ],
      "results": {
        "0": ["Low Risk; 2-day stroke risk 1.0%, 7-day stroke risk 1.2%, 90-day stroke risk 3.1%"],
        "1": ["Low Risk; 2-day stroke risk 1.0%, 7-day stroke risk 1.2%, 90-day stroke risk 3.1%"],
        "2": ["Low Risk; 2-day stroke risk 1.0%, 7-day stroke risk 1.2%, 90-day stroke risk 3.1%"],
        "3": ["Low Risk; 2-day stroke risk 1.0%, 7-day stroke risk 1.2%, 90-day stroke risk 3.1%"],
        "4": ["Moderate Risk; 2-day stroke risk 4.1%, 7-day stroke risk 5.9%, 90-day stroke risk 9.8%"],
        "5": ["Moderate Risk; 2-day stroke risk 4.1%, 7-day stroke risk 5.9%, 90-day stroke risk 9.8%"],
        "6": ["High Risk; 2-day stroke risk 8.1%, 7-day stroke risk 11.7%, 90-day stroke risk 17.8%"],
        "7": ["High Risk; 2-day stroke risk 8.1%, 7-day stroke risk 11.7%, 90-day stroke risk 17.8%"]
      },
      "notes": {
        "type": "unordered-list",
        "content": [
          "The ABCD2 score was developed to help stratify the stroke risk for patients presenting with a transient ischmeic attack (TIA).",
          "The score was developed in a non-emergency/outpatient setting. It has been shown to have lower accuracy when used by non-specialists.",
          "The largest prospective study using the ABCD2 score in the emergency department showed that the score performed poorly (low sensitivity for low risk patients and low specificity for high risk patients)",
          "Several other studies have shown that as the ABCD2 score increases the risk of a subsequent stroke increases",
          "Patients who have a low baseline risk of stroke (<2.0%) are at a low risk for having a stroke in the next 7 days (0.4-0.8%)"
        ]
      },
      "references": {
        "type": "ordered-list",
        "content": [
          "Johnston SC1, Rothwell PM, Nguyen-Huynh MN, Giles MF, Elkins JS, Bernstein AL, Sidney S. Validation and refinement of scores to predict very early stroke risk after transient ischaemic attack. Lancet. 2007 Jan 27;369(9558):283-92."
        ]
      }

    },
    {
      "id": "has-bled-score-for-major-bleeding-risk",
      "title": "HAS-BLED Score for Major Bleeding Risk",
      "type": "points",
      "points": 0,
      "questions": [
        {
          "group": "Criteria",
          "data": [
            {
              "type": "checkbox",
              "label": "Uncontrolled hypertension (Systolic ≥ 160mmHg)",
              "points": "1"
            },
            {
              "type": "checkbox",
              "label": "Renal disease (Dialysis, transplant or Creatinine >2.26mg/dL (200µmol/L)",
              "points": "1"
            },
            {
              "type": "checkbox",
              "label": "Liver disease (Cirrhosis or bilirubin levels >2x normal with AST/ALT/AP >3x normal)",
              "points": "1"
            },
            {
              "type": "checkbox",
              "label": "Stroke history",
              "points": "1"
            },
            {
              "type": "checkbox",
              "label": "Prior major bleeding or predisposition to bleeding",
              "points": "1"
            },
            {
              "type": "checkbox",
              "label": "Labile INR (Unstable/High INRs, time in therapeutic range <60%)",
              "points": "1"
            },
            {
              "type": "checkbox",
              "label": "Alcohol use ≥ 8 drinks/week",
              "points": "1"
            },
            {
              "type": "checkbox",
              "label": "Age > 65 yrs",
              "points": "1"
            },
            {
              "type": "checkbox",
              "label": "Medication usage that predisposes patient to bleeding (NSAIDs, Antiplatelet agents)",
              "points": "1"
            }
          ]
        }
      ],
      "results": {
        "0": [
          "Low Risk for major bleeding (~1 in 100 patient years); Anticoagulation should be considered"
        ],
        "1": [
          "Low Risk for major bleeding (~1 in 100 patient years); Anticoagulation should be considered"
        ],
        "2": [
          "Moderate Risk for major bleeding (~2 in 100 patient years); Anticoagulation can be considered"
        ],
        "3": [
          "High Risk for major bleeding; Alternatives to anticoagulation should be considered"
        ],
        "4": [
          "High Risk for major bleeding; Alternatives to anticoagulation should be considered"
        ],
        "5": [
          "High Risk for major bleeding; Alternatives to anticoagulation should be considered"
        ],
        "6": [
          "High Risk for major bleeding; Alternatives to anticoagulation should be considered"
        ],
        "7": [
          "High Risk for major bleeding; Alternatives to anticoagulation should be considered"
        ],
        "8": [
          "High Risk for major bleeding; Alternatives to anticoagulation should be considered"
        ],
        "9": [
          "High Risk for major bleeding; Alternatives to anticoagulation should be considered"
        ],
        "10": [
          "High Risk for major bleeding; Alternatives to anticoagulation should be considered"
        ]
      },
      "notes": {
        "type": "unordered-list",
        "content": [
          "HAS-BLED Score estimates the risk of major bleeding for atrial fibrillation patients to determine whether to start anticoagulation therapy",
          "Scores >5 were too rare to determine risk but the risk of major bleeding is likely >10%",
          "A study comparing HAS-BLED to HEMORR2HAGES and ATRIA showed the HAS-BLED score was superior in assessing risk"
        ]
      },
      "references": {
        "type": "ordered-list",
        "content": [
          "Pisters R, Lane DA, Nieuwlaat R, de Vos CB, Crijns HJ, Lip GY. A novel user-friendly score (HAS-BLED) to assess 1-year risk of major bleeding in patients with atrial fibrillation: the Euro Heart Survey. Chest. 2010 Nov;138(5):1093-100. doi: 10.1378/chest.10-0134. Epub 2010 Mar 18.",
          "Lip GY, Frison L, Halperin JL, Lane DA. Comparative validation of a novel risk score for predicting bleeding risk in anticoagulated patients with atrial fibrillation: the HAS-BLED (Hypertension, Abnormal Renal/Liver Function, Stroke, Bleeding History or Predisposition, Labile INR, Elderly, Drugs/Alcohol Concomitantly) score. J Am Coll Cardiol. 2011 Jan 11;57(2):173-80. doi: 10.1016/j.jacc.2010.09.024. Epub 2010 Nov 24."
        ]
      }
    },
    {
      "id": "cardiac-risk-index-aaa-surgery-lee",
      "title": "Cardiac Risk Index for AAA Surgery (Lee)",
      "type": "points",
      "points": 0,
      "questions": [
        {
          "group": "Criteria",
          "data": [
            {
              "type": "checkbox",
              "label": "Patient has Coronary artery disease (MI or positive stress test)",
              "points": "1"
            },
            {
              "type": "checkbox",
              "label": "History of Congestive Heart Failure",
              "points": "1"
            },
            {
              "type": "checkbox",
              "label": "History of Cerebrovascular disease (TIA or stroke)",
              "points": "1"
            },
            {
              "type": "checkbox",
              "label": "Patient has diabetes and is on insulin",
              "points": "1"
            },
            {
              "type": "checkbox",
              "label": "Chronic renal insufficiency (Creatinine > 2mg/dL or 176.8 µmol/L)",
              "points": "1"
            }
          ]
        }
      ],
      "results": {
        "0": [
          "Approximate risk of cardiac complication: up to 7%"
        ],
        "1": [
          "Approximate risk of cardiac complication: up to 7%"
        ],
        "2": [
          "Approximate risk of cardiac complication: 3.8%"
        ],
        "3": [
          "Approximate risk of cardiac complication: 11.5%"
        ],
        "4": [
          "Approximate risk of cardiac complication: 11.5%"
        ],
        "5": [
          "Approximate risk of cardiac complication: 11.5%"
        ]
      },
      "notes": {
        "type": "unordered-list",
        "content": [
          "The index score helps to identify patients at higher risk for cardiac complications post surgery",
          "In the Lee study, patients with 2 risk factors had a paradoxical decrease in cardiac complication rates"
        ]
      },
      "references": {
        "type": "ordered-list",
        "content": [
          "Lee TH, Marcantonio ER, Mangione CM, et al. Derivation and prospective validation of a simple index for prediction of cardiac risk of major noncardiac surgery. Circulation. 1999; 100: 1043-9."
        ]
      }
    },
    {
      "id": "cardiac-risk-index-abdominal-surgery-lee",
      "title": "Cardiac Risk Index for Abdominal Surgery (Lee)",
      "type": "points",
      "points": 0,
      "questions": [
        {
          "group": "Criteria",
          "data": [
            {
              "type": "checkbox",
              "label": "Patient has Coronary artery disease (MI or positive stress test)",
              "points": "1"
            },
            {
              "type": "checkbox",
              "label": "History of Congestive Heart Failure",
              "points": "1"
            },
            {
              "type": "checkbox",
              "label": "History of Cerebrovascular disease (TIA or stroke)",
              "points": "1"
            },
            {
              "type": "checkbox",
              "label": "Patient has diabetes and is on insulin",
              "points": "1"
            },
            {
              "type": "checkbox",
              "label": "Chronic renal insufficiency (Creatinine > 2mg/dL or 176.8 µmol/L)",
              "points": "1"
            }
          ]
        }
      ],
      "results": {
        "0": [
          "Approximate risk of cardiac complication: <1%"
        ],
        "1": [
          "Approximate risk of cardiac complication: <1%"
        ],
        "2": [
          "Approximate risk of cardiac complication: 3%"
        ],
        "3": [
          "Approximate risk of cardiac complication: 8.1%"
        ],
        "4": [
          "Approximate risk of cardiac complication: 8.1%"
        ],
        "5": [
          "Approximate risk of cardiac complication: 8.1%"
        ]
      },
      "references": {
        "type": "ordered-list",
        "content": [
          "Lee TH, Marcantonio ER, Mangione CM, et al. Derivation and prospective validation of a simple index for prediction of cardiac risk of major noncardiac surgery. Circulation. 1999; 100: 1043-9."
        ]
      }
    },
    {
      "id": "cardiac-risk-index-non-aaa-vascular-surgery-lee",
      "title": "Cardiac Risk Index for Non-AAA Vascular Surgery (Lee)",
      "type": "points",
      "points": 0,
      "questions": [
        {
          "group": "Criteria",
          "data": [
            {
              "type": "checkbox",
              "label": "Planned surgery type is high risk",
              "points": "1"
            },
            {
              "type": "checkbox",
              "label": "History of Coronary Artery disease",
              "points": "1"
            },
            {
              "type": "checkbox",
              "label": "History of Congestive Heart Failure",
              "points": "1"
            },
            {
              "type": "checkbox",
              "label": "History of Cerebrovascular disease(TIA or stroke)",
              "points": "1"
            },
            {
              "type": "checkbox",
              "label": "Patient has diabetes and is on insulin",
              "points": "1"
            },
            {
              "type": "checkbox",
              "label": "Chronic renal insufficiency (Creatinine > 2mg/dL or 176.8 µmol/L)",
              "points": "1"
            }
          ]
        }
      ],
      "results": {
        "0": [
          "Approximate risk of cardiac complication: <1%"
        ],
        "1": [
          "Approximate risk of cardiac complication: <1%"
        ],
        "2": [
          "Approximate risk of cardiac complication: 8%"
        ],
        "3": [
          "Approximate risk of cardiac complication: 12.5%"
        ],
        "4": [
          "Approximate risk of cardiac complication: 12.5%"
        ],
        "5": [
          "Approximate risk of cardiac complication: 12.5%"
        ],
        "6": [
          "Approximate risk of cardiac complication: 12.5%"
        ]
      },
      "references": {
        "type": "ordered-list",
        "content": [
          "Lee TH, Marcantonio ER, Mangione CM, et al. Derivation and prospective validation of a simple index for prediction of cardiac risk of major noncardiac surgery. Circulation. 1999; 100: 1043-9."
        ]
      }
    }
    ]
}
